Source: Cannabix Technologies Inc.
  • Cannabix (CSE:BLO) is developing marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safety
  • The Vancouver-based cannabis company reported that its proprietary laboratory-based marijuana detection equipment has detected THC in breath samples after edibles were consumed
  • The team has already begun discussions with forensic laboratory organizations on how to best integrate its novel MSBS hardware into current forensic testing and analysis methods
  • Cannabix Technologies Inc. (BLO) opened trading at $0.27 per share

Cannabix (CSE:BLO) is developing marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safety.

The Vancouver-based cannabis company reported that its proprietary laboratory-based marijuana detection equipment has detected THC (∆9-tetrahydrocannabinol) in breath samples after edibles were consumed.

Cannabix’s Mass Spectrometer Breath Sampler (MSBS) technology, along with the handheld Breath Collection Unit (BCU), have been providing consistent results in the detection of THC in breath from smoking. MSBS technology has shown the sensitivity in the low picogram range for THC in breath allowing for detection of THC from smoking and edibles up to four hours after consumption.

Source: Cannabix Technologies Inc.

The MSBS is a novel method to collect analytes of low volatility from a person’s breath utilizing liquid secondary adsorption. The company explained that this concept has successfully demonstrated efficient capturing and releasing of THC. Using the breath aerosol as a carrier of solid and viscous liquid particle analytes, this method used a secondary adsorbent to prevent sample loss.

After eating an edible containing marijuana, THC is absorbed into the bloodstream through the digestive tract and undergoes a first metabolic pass in the liver before entering general circulation. Metabolism through the liver further reduces the amount of analyte that makes its way through to the breath relative to smoking.

The team has already begun discussions with forensic laboratory organizations on how to best integrate its novel MSBS hardware into current forensic testing and analysis methods.

Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies for law enforcement and the workplace. The company recently filed a patent application to detect volatile organic compounds without a mouthpiece or straws. It developed this contactless alcohol breathalyzer technology for workplaces (a wall-mounted version) and an in-cabin vehicle version. Click here to read more.

Cannabix Technologies Inc. (BLO) opened trading at $0.27 per share.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

More From The Market Online

@ the Bell: TSX recovers and S&P hits fresh high

Energy shares led enough of a rally to overcome industrials and tech losses to push the TSX to a positive end on Tuesday.

Pathologists group accepts Telo Genomics’ test for rare blood cancer

The College of American Pathologists accepts the Telo Genomics' (TSXV:TELO) submission of a test for a rare blood cancer.

Theralase adds cancer immunotherapy to potential revenue streams

Theralase Technologies' (TSXV:TLT) lead drug candidate, Rutherrin, enhanced cancer immunotherapy in a pre-clinical setting.